BivastatBivalirudin
Bivastat is marketed by Cipla. 1 pack on NPPA's price list for July 2026, containing Bivalirudin.
- Packs listed
- 1
- Lowest MRP
- ₹7,487
- Per unit
- ₹1,497
- Price-controlled packs
- 0 of 1
- Dosage forms
- 1
Packs and prices
- ₹7,487Bivastat 250 mg Injection 5 mlBivalirudin Injection 250 mg · ₹1,497 per ml
The same composition from other brands
Packs with the identical filed composition, form and strength. A different brand is not automatically interchangeable: ask your doctor or pharmacist.
Bivalirudin Injection 250 mg
- ₹11,490/injectionBivasave · 1 injectionAbbott Healthcare · MRP ₹11,490
1 other brand of this composition on the price list; the 1 lowest per ml are shown. All Bivalirudin packs
The company
Cipla has 2,443 packs on the price list, and CDSCO has named it as the manufacturer of 23 failed batches since Jun 2013. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.